Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Skye Bioscience (SKYE)
NASDAQ:SKYE
Skye Bioscience (SKYE) Stock Price & Analysis
114 Followers
SKYE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $19.41
Previous Close$16.25
Volume23.35K
Average Volume (3M)32.24K
Market Cap
$364.82M
Enterprise Value$368.18M
Total Cash (Recent Filing)$1.26M
Total Debt (Recent Filing)$4.62M
Price to Earnings (P/E)-2.9
Beta0.87
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.70
Shares Outstanding28,062,907
10 Day Avg. Volume44,806
30 Day Avg. Volume32,238
Standard Deviation0.47
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-171.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-23.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-10.25
Forecast
1Y Price Target
$22.50Price Target Upside75.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Skye Bioscience News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SKYE FAQ
What was Skye Bioscience’s price range in the past 12 months?
Skye Bioscience lowest stock price was <$0.01 and its highest was $19.41 in the past 12 months.
What is Skye Bioscience’s market cap?
Currently, no data Available
When is Skye Bioscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Skye Bioscience’s earnings last quarter?
Currently, no data Available
Is Skye Bioscience overvalued?
According to Wall Street analysts Skye Bioscience’s price is currently Undervalued.
Does Skye Bioscience pay dividends?
Skye Bioscience does not currently pay dividends.
What is Skye Bioscience’s EPS estimate?
Skye Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Skye Bioscience have?
Skye Bioscience has 28,062,906 shares outstanding.
What happened to Skye Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Skye Bioscience?
Currently, no hedge funds are holding shares in SKYE
---
Skye Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (75.64% Upside)
$22.50 (75.64% Upside)
Insider Transactions
Bought Shares
Worth $16.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81150.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
31.05%
Trailing 12-Months
Company Description
Skye Bioscience
Emerald Bioscience, Inc. engages on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. The company was founded on March 16, 2011 and is headquartered in Long Beach, CA.
---
SKYE Stock 12 Months Forecast
Average Price Target
$22.50
▲(75.64% Upside)
Technical Analysis
Best Analysts Covering SKYE
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+95.70%
reiterated a buy rating last month
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +95.70% per trade.
---